Daily FNArena News

Southern Cross Equities has upgraded Mesoblast to Buy from Speculative Buy.

The TechWizard reports 1.0250 has now become the key technical level for AUD/USD.

Genetically engineered organisms could potentially make the US energy independent within a decade, reports Investment U’s Steve McDonald.

Investors thinking this is but a temporary blip caused by a deluded Gaddafi are in for a rude awakening.

Technical analysis suggests Telstra shares seem poised for potentially much lower price levels, The Chartist reports.

Danske Bank argues there is more to the ramifications of Arab unrest than just a temporary oil price spike. And while we’re at it, don’t mention Nigeria.

Technical market analysts see pressure increasing on USD while highlighting this further stimulates commodities.

Australian REITs outperformed the broader market in February, brokers attributing this to a solid profit season and cautious optimism on the part of management.

Drilling products and services provider Imdex reported strong interim earnings and Moelis sees further growth potential in coming years.

In the wake of the result season brokers have begun to reshape their lists of stocks to which they feel the most committed. Macquarie, UBS and Goldman Sachs are featured here.